3 active not recruiting, 3 completed, 1 terminated. 2 Not applicable, 2 Phase 1, 2 Phase 2, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Terminated 1 |
| Phase 1 | 2 | Active not recruiting 1, Completed 1 |
| Phase 2 | 2 | Active not recruiting 2 |
| Phase 3 | 1 | Active not recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow EpiCeram: new trials by email Literature Review of EpiCeram trials Research Report on EpiCeram
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Seal, Stopping Eczema and Allergy Study Tri-lipid skin barrier cream (Epiceram), Fluticasone propionate Cream 0.05%, Standard of Care - Eczema, Infantile, Eczema | Phase 2 | Active not recruiting | Kari Nadeau, MD, PhD | 398 | 2021-06-30 | 2026-02-27 |
| EpiCeram for Skin Protection in Healthcare Workers EpiCeram - Irritant Contact Dermatitis | Not applicable | Terminated | Primus Pharmaceuticals | 1 | 2021-03-15 | 2024-08-28 |
| Wound Healing Endpoint and Recurrence Epiceram Skin Barrier Function, Vaseline Petroleum Jelly - Chronic Wound, Burn Wound | Phase 1 / Phase 2 | Active not recruiting | Sashwati Roy | 100 | 2019-01-08 | 2025-09-26 |
| Effect of Different Skin Creams on TEWL EpiCeram, Aveeno Daily Moisturising Sheer Hydration Lotion® - Dermatitis, Atopic | Phase 1 | Completed | Stanford University | 17 | 2018-09-01 | 2021-09-08 |
| The PEBBLES Study - Testing a Strategy for Preventing Eczema and Food Allergy in High Risk Infants EpiCeram - Eczema, Asthma | Phase 3 | Active not recruiting | University of Melbourne | 760 | 2018-03-06 | 2023-05-10 |
| Human Testing of an Over-the-Counter (OTC) Cream in Children With Eczema Colloidal Oatmeal, Topical Cream - Atopic Dermatitis | Not applicable | Completed | Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. | 90 | 2011-03-01 | 2012-08-03 |
| Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis Atopiclair Nonsteroidal Cream, Aquaphor Healing Ointment, EpiCeram - Atopic Dermatitis | Phase 4 | Completed | Wake Forest University Health Sciences | 39 | 2009-09-01 | 2018-09-11 |
Dermatitis, Atopic (4) · Dermatitis (3) · Eczema (3) · Food Hypersensitivity (2) · Asthma (1) · Bronchiolitis Obliterans Syndrome (1) · Burns (1) · Dermatitis, Irritant (1) · Diabetic Foot (1) · Pressure Ulcer (1) · Wounds and Injuries (1)
Johnson & Johnson Consumer Products Company Division of Johnson & Johnson Consumer Companies, Inc. (1) · Kari Nadeau, MD, PhD (1) · Primus Pharmaceuticals (1) · Sashwati Roy (1) · Stanford University (1) · University of Melbourne (1) · Wake Forest University Health Sciences (1)
United States (6) · Australia (1) · United Kingdom (1)
Adrian J Lowe, Doctorate (1) · Alan Fleischer, MD (1) · Kari Nadeau, M.D., PhD (1) · Kari Nadeau, MD, PhD (1) · Qing Li, MD, PhD (1) · Robert Levy, MD (1) · Sashwati Roy, PhD (1) · Sayantani Sindher, M.D. (1)
PMID 21533301, PMID 28366039, PMID 30867201, PMID 34398099
U01AI147462 (1)